TLDR GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.
This scoping review investigated the use of GLP-1 receptor agonists (GLP-1 RAs) for weight loss in women with polycystic ovary syndrome (PCOS), analyzing eight studies from a pool of 811 articles. The studies consistently showed that GLP-1 RAs, such as liraglutide and exenatide, led to reductions in weight and BMI, as well as improvements in anthropometric parameters, glucose homeostasis, cardiovascular markers, menstrual regularity, and pregnancy rates. However, the impact on lipid profiles was inconsistent, and while some short-term adverse effects were noted, the long-term effects remain unclear. The findings suggest promising outcomes for GLP-1 RA use in PCOS, but further research is needed to fully understand the therapy's adverse effects.
317 citations
,
April 2018 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology” PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.
1265 citations
,
October 2013 in “The Journal of Clinical Endocrinology and Metabolism” The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.
59 citations
,
August 2021 in “Frontiers in Endocrinology” GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.
July 2023 in “Journal of Clinical Medicine” Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.
December 2024 in “African Journal of Biomedical Research” Combining lifestyle changes and medication is most effective for managing PCOS symptoms.
September 2025 in “Cureus” GLP-1 agonists may help treat certain skin conditions.
February 2024 in “Journal of Education, Health and Sport” Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.
